Rejoint received a €3MM (~US $3.4MM) grant from the EU’s Horizon 2020 SME Innovation and Research Program as a recipient of the Fast Track to Innovation award. Funds will support commercialization of the YourKnee™ total knee replacement system.
The YourKnee approach combines elements of 3D printing, patient-specific implants, artificial intelligence and wearables to design personalized implants, surgical simulation and post-op rehabilitation tools for every patient.
Mechanical testing of the system was successfully completed in 4Q18.
Among others, Rejoint has partnered with the information technology EU joint venture formed between Sensoria Health in the U.S. and ICT in the Netherlands, as well as the Italian computer-aided surgery company Orthokey and FundacioÌn Rioja Salud Research Hospital in Spain.
Sources: Rejoint, ORTHOWORLD Inc.
Rejoint received a €3MM (~US $3.4MM) grant from the EU's Horizon 2020 SME Innovation and Research Program as a recipient of the Fast Track to Innovation award. Funds will support commercialization of the YourKnee™ total knee replacement system.
The YourKnee approach combines elements of 3D printing, patient-specific implants, artificial...
Rejoint received a €3MM (~US $3.4MM) grant from the EU’s Horizon 2020 SME Innovation and Research Program as a recipient of the Fast Track to Innovation award. Funds will support commercialization of the YourKnee™ total knee replacement system.
The YourKnee approach combines elements of 3D printing, patient-specific implants, artificial intelligence and wearables to design personalized implants, surgical simulation and post-op rehabilitation tools for every patient.
Mechanical testing of the system was successfully completed in 4Q18.
Among others, Rejoint has partnered with the information technology EU joint venture formed between Sensoria Health in the U.S. and ICT in the Netherlands, as well as the Italian computer-aided surgery company Orthokey and FundacioÌn Rioja Salud Research Hospital in Spain.
Sources: Rejoint, ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
